Barbara Shih

Dr. Barbara Shih

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2010 in Wound Repair and Regeneration
Verified
Journal Article
Closed access
PDF file
BSBarbara Shih
Barbara Shih
EGElloise Garside
Elloise Garside
DMDuncan Angus McGrouther
Duncan Angus McGrouther
ABArdeshir Bayat
Ardeshir Bayat

4 February 2010 in Archives of Dermatological Research
Verified
Journal Article
Closed access
BSBarbara Shih
Barbara Shih
ABArdeshir Bayat
Ardeshir Bayat

9 November 2010 in Nature Reviews Rheumatology
Verified
Journal Article
Closed access
BSBarbara Shih
Barbara Shih
ABArdeshir Bayat
Ardeshir Bayat

25 July 2022 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
TFTom C. Freeman
Tom C. Freeman
SHSebastian Horsewell
Sebastian Horsewell
APAnirudh Patir
Anirudh Patir
JHJosh Harling-Lee
Josh Harling-Lee
Tim ReganTim Regan
Tim Regan
TATim Angus
Tim Angus
Graphia is an open-source platform created for the graph-based analysis of the huge amounts of quantitative and qualitative data currently being generated from the study of genomes, genes, proteins metabolites and cells. Core to Graphia’s functionality is support for the calculation of correlation matrices from any tabular matrix of continuous or discrete values, whereupon the software is designed to rapidly visualise the often very large graphs that result in 2D or 3D space. Following graph construction, an extensive range of measurement algorithms, routines for graph transformation, and options for the visualisation of node and edge attributes are available, for graph exploration and analysis. Combined, these provide a powerful solution for the interpretation of high-dimensional data from many sources, or data already in the form of a network or equivalent adjacency matrix. Several use cases of Graphia are described, to showcase its wide range of applications in the analysis biological data. Graphia runs on all major desktop operating systems, is extensible through the deployment of plugins and is freely available to download from https://graphia.app/.

27 August 2021 in Transboundary and Emerging Diseases
Verified
Journal Article
Open access
PDF file
JFJohn T Flannery
John T Flannery
BSBarbara Shih
Barbara Shih
IHIsmar R. Haga
Ismar R. Haga
MAMartin Ashby
Martin Ashby
ACAmanda Corla
Amanda Corla
PBPhilippa M Beard
Philippa M Beard
Lumpy skin disease virus (LSDV) is an emerging poxviral pathogen of cattle that is currently spreading throughout Asia. The disease situation is of high importance for farmers and policy makers in Asia. In October 2020, feral cattle in Hong Kong developed multi‐focal cutaneous nodules consistent with lumpy skin disease (LSD). Gross and histological pathology further supported the diagnosis and samples were sent to the OIE Reference Laboratory at The Pirbright Institute for confirmatory testing. LSDV was detected using quantitative polymerase chain reaction (qPCR) and additional molecular analyses. This is the first report of LSD in Hong Kong. Whole genome sequencing (WGS) of the strain LSDV/Hong Kong/2020 and phylogenetic analysis were carried out in order to identify connections to previous outbreaks of LSD, and better understand the drivers of LSDV emergence. Analysis of the 90 core poxvirus genes revealed LSDV/Hong Kong/2020 was a novel strain most closely related to the live‐attenuated Neethling vaccine strains of LSDV and more distantly related to wildtype LSDV isolates from Africa, the Middle East and Europe. Analysis of the more variable regions located towards the termini of the poxvirus genome revealed genes in LSDV/Hong Kong/2020 with different patterns of grouping when compared to previously published wildtype and vaccine strains of LSDV. This work reveals that the LSD outbreak in Hong Kong in 2020 was caused by a different strain of LSDV than the LSD epidemic in the Middle East and Europe in 2015–2018. The use of WGS is highly recommended when investigating LSDV disease outbreaks.

1 October 2018 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
BSBarbara Shih
Barbara Shih
MFMark Farrar
Mark Farrar
MCMarcus Cooke
Marcus Cooke
JOJoanne Osman
Joanne Osman
ALAbigail Kate Langton
Abigail Kate Langton
LRLesley Rhodes
Lesley Rhodes
Public health guidance recommends limiting sun exposure to sub-sunburn levels, but it is unknown whether these can gain vitamin D (for musculoskeletal health) while avoiding epidermal DNA damage (initiates skin cancer). Well-characterized healthy humans of all skin types (I-VI, lightest to darkest skin) were exposed to a low-dose series of solar simulated UVR of 20%-80% their individual sunburn threshold dose (minimal erythema dose). Significant UVR dose responses were seen for serum 25-hydroxyvitamin D and whole epidermal cyclobutane pyrimidine dimers (CPDs), with as little as 0.2 minimal erythema dose concurrently producing 25-hydroxyvitamin D and CPD. Fractional MEDs generated equivalent levels of whole epidermal CPD and 25-hydroxyvitamin D across all skin types. Crucially, we showed an epidermal gradient of CPD formation strongly correlated with skin darkness (r = 0.74, P < 0.0001), which reflected melanin content and showed increasing protection across the skin types, ranging from darkest skin, where high CPD levels occurred superficially, with none in the germinative basal layer, to lightest skin, where CPD levels were induced evenly across the epidermal depth. People with darker skin can be encouraged to use sub-sunburn UVR-exposure to enhance their vitamin D. In people with lighter skin, basal cell damage occurs concurrent with vitamin D synthesis at exquisitely low UVR levels, providing an explanation for their high skin cancer incidence; greater caution is required.